[Determination of antigen expression levels of uPA and PAI-1 in primary breast cancer with intermediate recurrence risk after R0 primary surgery]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003013
German
Original Title:
Bestimmung der Antigenexpressionslevel von uPA und PAI-1 beim primaeren Mammakarzinom mit intermediaerem Rueckfallrisiko nach R0-Primaeroperation
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/d13-02.html
Year Published:
2014
URL for published report:
https://www.iqwig.de/download/D13-02_Abschlussbericht_Antigenexpression-bei-Mammakarzinom.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Breast Neoplasms
- Urokinase-Type Plasminogen Activator
- Plasminogen Activator Inhibitor 1
- Biomarkers, Tumor
Keywords
- Urokinase-Type Plasminogen Activator
- Plasminogen Activator Inhibitor 1
- Breast Neoplasms
- Benefit Assessment
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.